Navigation Links
Hillenbrand Expects to Report Second-Quarter Net Revenue of $170.8 Million and Revises 2009 Guidance
Date:4/9/2009

- Decreased industry-wide demand drove reduced Q2 revenues, which results in 6 percent lower full-year revenue guidance.

- Cost reductions, including lower litigation expenses, yield a 2 percent increase in diluted earnings per share compared to previous guidance.

BATESVILLE, Ind., April 9 /PRNewswire-FirstCall/ -- Hillenbrand, Inc. (NYSE: HI) is revising its 2009 guidance, based on lower-than-expected revenue of $170.8 million during its second fiscal quarter. For the full 2009 fiscal year, the company expects revenues to range from $650 million to $670 million, a reduction of approximately 6 percent from previous revenue guidance. In addition, GAAP diluted earnings per share have been adjusted upward to a range of $1.57 to $1.70, reflecting an increase of approximately 2 percent from prior guidance.

"Our business is dependent on the seasonal effects on burials, and the decline we've seen is consistent with public reports from our customers and competitors," said Kenneth A. Camp, president and chief executive officer of Hillenbrand, Inc. "We will manage successfully through this downturn and are taking decisive actions to ensure our long-term market presence and to manage costs without decreasing service to our customers or reducing future growth investments."

Lower revenues in the second quarter are the result of an industry-wide decrease in demand for caskets. The largest driver of decreased demand is the very mild pneumonia and influenza season, especially compared to the prior year when the flu surpassed epidemic levels throughout much of the country. The company believes it has experienced an increased level of competition during the second fiscal quarter as competitors are similarly affected by the reduced demand.

Two other key factors are expected to have a positive effect on expenses during the remainder of the fiscal year. Prices for diesel fuel have been below the levels experienced in the previous year, and the company has recently negotiated more favorable contracts on steel and selected other commodities. In addition, litigation costs for the remainder of fiscal 2009 are expected to decline to $7 million from our previous estimate of $18.5 million because of recent court rulings in its class-action litigation. The litigation cost estimate is dependent on the potential for an appeal by the plaintiffs.

Conference Call and Webcast

Hillenbrand will report its second-quarter earnings on May 11, 2009, and will provide further details and perspectives on fiscal 2009 at that time. The conference call and webcast will take place at 11 a.m. ET Monday, May 11, 2009. The webcast will be available at http://ir.hillenbrandinc.com and will be archived on the company's Web site through May 10, 2010, for those unable to listen to the live webcast.

Participants may listen to the conference call by dialing 1-877-718-5092 (1-719-325-4807 for international callers). A replay of the call will be available through midnight Monday, May 25, 2009, at 1-888-203-1112 (1-719-457-0820 for international callers). Please use the confirmation code 7352147.

Outlook for Fiscal Year 2009

The company is adjusting its fiscal 2009 full-year guidance as follows:

  • Revenues in the range of $650 million to $670 million, compared to prior guidance of $695 million to $710 million.
  • GAAP diluted earnings per share for the year of $1.57 to $1.70, compared to prior guidance of $1.54 to $1.66. This includes the pre-tax reduction in antitrust expenses of $11.5 million resulting from favorable proceedings in the antitrust litigation.
  • Estimated diluted earnings per share, excluding certain non-operating costs (primarily antitrust litigation expenses), for the year are $1.65 to $1.78.

    Hillenbrand, Inc.
    (amounts in millions, except per share data)

                                   Fiscal year ending September 30
                                              FY 09 Range
                                 FY 08       Low       High

    Net revenues                  $678       $650      $670
    Income before taxes           $153       $152      $162
    Tax rate                      39.2%      36.4%     35.4%
    Net income                     $93        $97      $105
    Average diluted shares
     outstanding                    63         61        61
    Diluted net income per
     share                       $1.49      $1.57     $1.70


    Excluding certain
     non-operating costs
      (antitrust litigation and
        separation*)
       Net income                 $108       $101      $109
       Diluted net income per
        share                    $1.73      $1.65     $1.78



*Non-GAAP Financial Disclosures and Reconciliations for Fiscal Year 2009

While Hillenbrand, Inc. reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hillenbrand uses the non-GAAP measures to evaluate and manage its operations and provides the information to investors so they can see the results "through the eyes" of management. Hillenbrand further believes that providing this information better enables investors to understand the ongoing operating performance of the company. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

    Hillenbrand, Inc.
    (amounts in millions)
                                12 Months Ended          Fiscal Year 2009
                               September 30, 2008       Guidance Midpoint
                            Pre-   Income  Post-Tax   Pre-   Income  Post-Tax
                            Tax    Taxes              Tax    Taxes

    GAAP income            $153.3   $60.1    $93.2   $156.9   $56.3    $100.6

    Certain
    non-operating costs:
      Antitrust litigation    3.3     1.2      2.1      7.0     2.6       4.4
      Separation             15.6     2.6     13.0      0.2     0.1       0.1

    Adjusted income        $172.2   $63.9   $108.3   $164.1   $59.0    $105.1


Disclosure Regarding Forward-Looking Statements

Throughout this release, we make a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. As the words imply, "forward-looking statements" are statements about the future, as contrasted with historical information. Our forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature they are subject to a wide range of risks.

Words that could indicate we're making forward-looking statements include the following:

     Intend      believe    plan          expect    may        goal
     Become      pursue     estimate      will      forecast   continue
     Targeted    increase   higher/lower  improve   progress   potential

This isn't an exhaustive list, but is simply intended to give you an idea of how we try to identify "forward-looking statements." The absence of any of these words, however, does not mean that the statement is not "forward-looking."

Here's the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors -- many of which are beyond our control -- could cause our performance to differ significantly from those described in the forward-looking statements. These factors include, but are not limited to: the company's ongoing antitrust litigation; the company's dependence on its relationships with several large national providers; continued fluctuations in mortality rates and increased cremations; ongoing involvement in claims, lawsuits and governmental proceedings related to operations; failure of the company's announced strategic initiatives to achieve expected growth, efficiencies or cost reductions; failure of the company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances; competition from nontraditional sources in the funeral services business; volatility of the company's investment portfolio; increased costs or unavailability of raw materials; labor disruptions; the ability to retain executive officers and other key personnel; and certain tax-related matters. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in item 1A of the company's Annual Report on Form 10-K for the year ended Sept. 30, 2008, filed Dec. 9, 2008. The company assumes no obligation to update or revise any forward-looking information.

About Hillenbrand, Inc.

Hillenbrand, Inc. (www.HillenbrandInc.com) is the holding company for Batesville Casket Company, a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing, and other personalization and memorialization products. HI-INC-F


'/>"/>
SOURCE Hillenbrand, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hillenbrand Board of Directors Appoints Joe Loughrey as New Director
2. Hillenbrand Announces Dividend of $0.185 Per Share
3. Hillenbrand, Inc. Announces Corrected First-Quarter Earnings Release and Conference Call Date
4. Hillenbrand, Inc. Announces First-Quarter Earnings Release Date and Conference Call
5. Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business
6. Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
7. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
8. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
9. Hillenbrand, Inc. Announces Analyst/Investor Conference in New York Dec. 3
10. Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
11. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2016)... ... 29, 2016 , ... Whole Health Supply is happy to announce the favorable ... via Amazon.com. This new style of nail clipper has a wider jaw opening that ... 4mm and the actual handle is 2.5mm thick to accommodate the cutting force. This ...
(Date:5/28/2016)... States of America (PRWEB) , ... May 28, 2016 , ... ... SuperCloset knows all too well the day to day issues, struggles and obstacles ... military. The Helping Veterans Grow Project provides active or retired military veteran(s) with ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the ... event. The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 at ... the United Kingdom came together to explore the many pathways individuals use to get into ...
(Date:5/27/2016)... ... 2016 , ... Southland Log Homes , designer and manufacturer of America’s ... which can be found on its website at SouthlandLogHomes.com. , The designs of the ... highlight the craftsmanship of timber post and beam construction. The result is a ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... campaign returns for a third time to shed lights on the variety of topics ... and inspirational stories, “Nurse Appreciation” tackles why this career has gone from being in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... Eye expert s ... seek an eye examination before leaving ...   Moorfields Eye Hospital Dubai, the first overseas branch ... , has identified premature babies as a special concern in the ... vulnerability to retinopathy of prematurity (ROP). ROP is a potentially blinding ...
(Date:5/27/2016)... Israel , May 27, 2016 ... of the Dario™ Diabetes Management Tool, today announced that the ... at the Marcum MicroCap Conference being held June 1-2 in ... Micro Invitational, being held June 7-9 in Los ... Ben-David will discuss recent corporate and operational milestones, including the ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
Breaking Medicine Technology: